Dyslipidemia and the progression of renal disease in chronic renal failure patients.

  title={Dyslipidemia and the progression of renal disease in chronic renal failure patients.},
  author={Aleix Cases and Elisabet Coll},
  journal={Kidney international. Supplement},
Dyslipidemia is a common complication of progressive kidney disease and contributes to the high cardiovascular morbidity and mortality of chronic kidney disease (CKD) patients. Recent evidence also suggests a role for dyslipidemia in the development and progression of renal disease. Experimental studies have demonstrated that lipids may induce glomerular and tubulointerstitial injury, and that lipid-lowering treatments ameliorate renal injury. Various lipid abnormalities have been associated… CONTINUE READING
Highly Cited
This paper has 127 citations. REVIEW CITATIONS


Publications citing this paper.
Showing 1-10 of 65 extracted citations

Dyslipidemia in patients with chronic kidney disease: etiology and management

International journal of nephrology and renovascular disease • 2017
View 8 Excerpts
Highly Influenced

Niacin in patients with chronic kidney disease: Is it effective and safe?

Kidney research and clinical practice • 2013
View 5 Excerpts
Highly Influenced

Native LDL-induced oxidative stress in human proximal tubular cells: multiple players involved

Journal of cellular and molecular medicine • 2011
View 4 Excerpts
Highly Influenced

Leveraging Association Rule Mining to Detect Pathophysiological Mechanisms of Chronic Kidney Disease Complicated by Metabolic Syndrome

2018 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) • 2018
View 1 Excerpt

127 Citations

Citations per Year
Semantic Scholar estimates that this publication has 127 citations based on the available data.

See our FAQ for additional information.